Cost-effectiveness of cognitive behavioural and personalized exercise interventions for reducing fatigue in inflammatory rheumatic diseases
© The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology..
OBJECTIVES: To estimate the cost-effectiveness of a cognitive behavioural approach (CBA) or a personalized exercise programme (PEP), alongside usual care (UC), in patients with inflammatory rheumatic diseases who report chronic, moderate to severe fatigue.
METHODS: A within-trial cost-utility analysis was conducted using individual patient data collected within a multicentre, three-arm randomized controlled trial over a 56-week period. The primary economic analysis was conducted from the UK National Health Service (NHS) perspective. Uncertainty was explored using cost-effectiveness acceptability curves and sensitivity analysis.
RESULTS: Complete-case analysis showed that, compared with UC, both PEP and CBA were more expensive [adjusted mean cost difference: PEP £569 (95% CI: £464, £665); CBA £845 (95% CI: £717, £993)] and, in the case of PEP, significantly more effective [adjusted mean quality-adjusted life year (QALY) difference: PEP 0.043 (95% CI: 0.019, 0.068); CBA 0.001 (95% CI: -0.022, 0.022)]. These led to an incremental cost-effectiveness ratio (ICER) of £13 159 for PEP vs UC, and £793 777 for CBA vs UC. Non-parametric bootstrapping showed that, at a threshold value of £20 000 per QALY gained, PEP had a probability of 88% of being cost-effective. In multiple imputation analysis, PEP was associated with significant incremental costs of £428 (95% CI: £324, £511) and a non-significant QALY gain of 0.016 (95% CI: -0.003, 0.035), leading to an ICER of £26 822 vs UC. The estimates from sensitivity analyses were consistent with these results.
CONCLUSION: The addition of a PEP alongside UC is likely to provide a cost-effective use of health care resources.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:62 |
|---|---|
| Enthalten in: |
Rheumatology (Oxford, England) - 62(2023), 12 vom: 01. Dez., Seite 3819-3827 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chong, Huey Yi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cognitive behavioural |
|---|
| Anmerkungen: |
Date Completed 04.12.2023 Date Revised 11.12.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/rheumatology/kead157 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM355228696 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM355228696 | ||
| 003 | DE-627 | ||
| 005 | 20231227131208.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/rheumatology/kead157 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1225.xml |
| 035 | |a (DE-627)NLM355228696 | ||
| 035 | |a (NLM)37018151 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chong, Huey Yi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cost-effectiveness of cognitive behavioural and personalized exercise interventions for reducing fatigue in inflammatory rheumatic diseases |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.12.2023 | ||
| 500 | |a Date Revised 11.12.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. | ||
| 520 | |a OBJECTIVES: To estimate the cost-effectiveness of a cognitive behavioural approach (CBA) or a personalized exercise programme (PEP), alongside usual care (UC), in patients with inflammatory rheumatic diseases who report chronic, moderate to severe fatigue | ||
| 520 | |a METHODS: A within-trial cost-utility analysis was conducted using individual patient data collected within a multicentre, three-arm randomized controlled trial over a 56-week period. The primary economic analysis was conducted from the UK National Health Service (NHS) perspective. Uncertainty was explored using cost-effectiveness acceptability curves and sensitivity analysis | ||
| 520 | |a RESULTS: Complete-case analysis showed that, compared with UC, both PEP and CBA were more expensive [adjusted mean cost difference: PEP £569 (95% CI: £464, £665); CBA £845 (95% CI: £717, £993)] and, in the case of PEP, significantly more effective [adjusted mean quality-adjusted life year (QALY) difference: PEP 0.043 (95% CI: 0.019, 0.068); CBA 0.001 (95% CI: -0.022, 0.022)]. These led to an incremental cost-effectiveness ratio (ICER) of £13 159 for PEP vs UC, and £793 777 for CBA vs UC. Non-parametric bootstrapping showed that, at a threshold value of £20 000 per QALY gained, PEP had a probability of 88% of being cost-effective. In multiple imputation analysis, PEP was associated with significant incremental costs of £428 (95% CI: £324, £511) and a non-significant QALY gain of 0.016 (95% CI: -0.003, 0.035), leading to an ICER of £26 822 vs UC. The estimates from sensitivity analyses were consistent with these results | ||
| 520 | |a CONCLUSION: The addition of a PEP alongside UC is likely to provide a cost-effective use of health care resources | ||
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a cognitive behavioural | |
| 650 | 4 | |a cost-effectiveness | |
| 650 | 4 | |a fatigue | |
| 650 | 4 | |a inflammatory rheumatic diseases | |
| 650 | 4 | |a personalized exercise | |
| 650 | 4 | |a remote delivery | |
| 700 | 1 | |a McNamee, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Bachmair, Eva-Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Martin, Kathryn |e verfasserin |4 aut | |
| 700 | 1 | |a Aucott, Lorna |e verfasserin |4 aut | |
| 700 | 1 | |a Dhaun, Neeraj |e verfasserin |4 aut | |
| 700 | 1 | |a Dures, Emma |e verfasserin |4 aut | |
| 700 | 1 | |a Emsley, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Gray, Stuart R |e verfasserin |4 aut | |
| 700 | 1 | |a Kidd, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Vinod |e verfasserin |4 aut | |
| 700 | 1 | |a Lovell, Karina |e verfasserin |4 aut | |
| 700 | 1 | |a MacLennan, Graeme |e verfasserin |4 aut | |
| 700 | 1 | |a Norrie, John |e verfasserin |4 aut | |
| 700 | 1 | |a Paul, Lorna |e verfasserin |4 aut | |
| 700 | 1 | |a Packham, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a Ralston, Stuart H |e verfasserin |4 aut | |
| 700 | 1 | |a Siebert, Stefan |e verfasserin |4 aut | |
| 700 | 1 | |a Wearden, Alison |e verfasserin |4 aut | |
| 700 | 1 | |a Macfarlane, Gary |e verfasserin |4 aut | |
| 700 | 1 | |a Basu, Neil |e verfasserin |4 aut | |
| 700 | 0 | |a LIFT Study Group |e verfasserin |4 aut | |
| 700 | 1 | |a Nicol, Amy |e investigator |4 oth | |
| 700 | 1 | |a Norris, Karen |e investigator |4 oth | |
| 700 | 1 | |a Mann, Sandra |e investigator |4 oth | |
| 700 | 1 | |a Van Lierop, Lorna |e investigator |4 oth | |
| 700 | 1 | |a Gomez, Eli |e investigator |4 oth | |
| 700 | 1 | |a McCurdy, Fiona |e investigator |4 oth | |
| 700 | 1 | |a Findlay, Valerie |e investigator |4 oth | |
| 700 | 1 | |a Hastie, Neil |e investigator |4 oth | |
| 700 | 1 | |a Morgan, Eunice |e investigator |4 oth | |
| 700 | 1 | |a Emmanuel, Roselyn |e investigator |4 oth | |
| 700 | 1 | |a Whibley, Daniel |e investigator |4 oth | |
| 700 | 1 | |a Urquart, Aimee |e investigator |4 oth | |
| 700 | 1 | |a MacPerson, Laura |e investigator |4 oth | |
| 700 | 1 | |a Rowland, Janice |e investigator |4 oth | |
| 700 | 1 | |a Kiddie, Gwen |e investigator |4 oth | |
| 700 | 1 | |a Pankhurst, Debbie |e investigator |4 oth | |
| 700 | 1 | |a Johnstone, Paul |e investigator |4 oth | |
| 700 | 1 | |a Nicholson, Hilary |e investigator |4 oth | |
| 700 | 1 | |a Dunsmore, Angela |e investigator |4 oth | |
| 700 | 1 | |a Knight, Alison |e investigator |4 oth | |
| 700 | 1 | |a Ellis, John |e investigator |4 oth | |
| 700 | 1 | |a Maclean, Callum |e investigator |4 oth | |
| 700 | 1 | |a Crighton, Linda |e investigator |4 oth | |
| 700 | 1 | |a Shearer, Cameron |e investigator |4 oth | |
| 700 | 1 | |a Coyle, Judy |e investigator |4 oth | |
| 700 | 1 | |a Begg, Susan |e investigator |4 oth | |
| 700 | 1 | |a Ackerman, Lyndsey |e investigator |4 oth | |
| 700 | 1 | |a Carnevale, Jill |e investigator |4 oth | |
| 700 | 1 | |a Arbuthnot, Samantha |e investigator |4 oth | |
| 700 | 1 | |a Watters, Helen |e investigator |4 oth | |
| 700 | 1 | |a Dockrell, Dervil |e investigator |4 oth | |
| 700 | 1 | |a Hamilton, Debbie |e investigator |4 oth | |
| 700 | 1 | |a Salutous, Dario |e investigator |4 oth | |
| 700 | 1 | |a Cathcart, Susanne |e investigator |4 oth | |
| 700 | 1 | |a Rimmer, Dominic |e investigator |4 oth | |
| 700 | 1 | |a Hughes, Emma |e investigator |4 oth | |
| 700 | 1 | |a Harvey, Juliet |e investigator |4 oth | |
| 700 | 1 | |a Gillies, Mairi |e investigator |4 oth | |
| 700 | 1 | |a Webster, Susan |e investigator |4 oth | |
| 700 | 1 | |a Milne, Leeanne |e investigator |4 oth | |
| 700 | 1 | |a Semple, Gary |e investigator |4 oth | |
| 700 | 1 | |a Duffy, Katharine |e investigator |4 oth | |
| 700 | 1 | |a Turner, Lynne |e investigator |4 oth | |
| 700 | 1 | |a Alexander, John |e investigator |4 oth | |
| 700 | 1 | |a Innes, June |e investigator |4 oth | |
| 700 | 1 | |a Clark, Charlotte |e investigator |4 oth | |
| 700 | 1 | |a Meek, Christine |e investigator |4 oth | |
| 700 | 1 | |a McKenna, Elizabeth |e investigator |4 oth | |
| 700 | 1 | |a Routledge, Christine |e investigator |4 oth | |
| 700 | 1 | |a Hinchcliffe-Hume, Helain |e investigator |4 oth | |
| 700 | 1 | |a Traianos, Emmanuella |e investigator |4 oth | |
| 700 | 1 | |a Dibnah, Beth |e investigator |4 oth | |
| 700 | 1 | |a Storey, David |e investigator |4 oth | |
| 700 | 1 | |a O'Callaghan, Gemma |e investigator |4 oth | |
| 700 | 1 | |a Baron, Jenny Yael |e investigator |4 oth | |
| 700 | 1 | |a Hunt, Sally |e investigator |4 oth | |
| 700 | 1 | |a Wheat, Natalie |e investigator |4 oth | |
| 700 | 1 | |a Smith, Pam |e investigator |4 oth | |
| 700 | 1 | |a Barcroft, Elizabeth Ann |e investigator |4 oth | |
| 700 | 1 | |a Thompson, Amy |e investigator |4 oth | |
| 700 | 1 | |a Tomlinson, Johanne |e investigator |4 oth | |
| 700 | 1 | |a Barber, Jill |e investigator |4 oth | |
| 700 | 1 | |a MacPerson, Gladys |e investigator |4 oth | |
| 700 | 1 | |a White, Peter |e investigator |4 oth | |
| 700 | 1 | |a Hewlett, Sarah |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Rheumatology (Oxford, England) |d 1999 |g 62(2023), 12 vom: 01. Dez., Seite 3819-3827 |w (DE-627)NLM102581908 |x 1462-0332 |7 nnns |
| 773 | 1 | 8 | |g volume:62 |g year:2023 |g number:12 |g day:01 |g month:12 |g pages:3819-3827 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/rheumatology/kead157 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 62 |j 2023 |e 12 |b 01 |c 12 |h 3819-3827 | ||